Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a poor prognosis.
Lung transplantation is the only intervention shown to increase life expectancy for patients …

Interstitial lung disease (ILD) is a cause of morbidity and mortality in patients with rheumatic
diseases, such as connective-tissue diseases, rheumatoid arthritis and systemic vasculitis …

Pulmonary complications in CTD are common and can involve the interstitium, airways,
pleura and pulmonary vasculature. ILD can occur in all CTD (CTD‐ILD), and may vary from …

Introduction Early and accurate diagnosis of interstitial lung diseases (ILDs) remains a major
challenge. Better noninvasive diagnostic tools are much needed. We aimed to assess the …

Breathlessness, dyspnoea and shortness of breath are synonymous terms to describe the
'subjective experience of breathing discomfort that consists of qualitatively distinct …

Background Idiopathic pulmonary fibrosis is a progressive fibrotic lung disease, with most
patients reporting cough. Currently, there are no proven treatments. We examined the use of …

Introduction Morphine may decrease the intensity of chronic breathlessness but data from a
large randomised controlled trial (RCT) are lacking. This first, large, parallel-group trial …

Systemic sclerosis (SSc) is a multi-organ autoimmune disease with complex interactions
between immune-mediated inflammatory processes and vascular pathology leading to small …

Idiopathic pulmonary fibrosis (IPF) is a progressive disease leading to significant morbidity
and mortality. In 2017 the Thoracic Society of Australia and New Zealand (TSANZ) and Lung …

Background and objective The management of symptoms in patients with advanced chronic
respiratory diseases needs more attention. This review summarizes the latest evidence on …